Oceanaa Biotek Industries Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Oceanaa Biotek Industries Ltd. on BSE

Search Inside the pdf :

Oceanaa Biotek Industries Ltd.

28 Jul 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director

BSE India

We wish to inform you that the Board of Directors at their meeting held today noted and approved the following: 1. Mr. Xavier Jeyaraj Sebastian has resigned as Director and Managing Director w.e.f 28th July 2021. 2. On recommendation of Nomination and Remuneration Committee, the Board of Directors of the company at its meeting held today (i.e) 28th July 2021 has appointed Mrs. Anbarasi Thenmozhi Thomas, as Managing Director of the Company for a period of Five (5) years commencing from 28th July 2021, subject to approval of members in the ensuing General Meeting. Whereas, he is appointed as on Additional Director of the company w.e.f 30th June 2021. Further, the disclosures as required under Regulation 30 of the SEBI Regulations read with SEBI Circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015 is given in Annexure 1. Kindly acknowledge receipt of the same.

pdf

Oceanaa Biotek Industries Ltd.

17 Jul 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to the provisions of SEBI Circular CIR/CFD/CMD1/27/2019 dated February 8, 2019 and Regulation 24A of the of SEBI (Listing Obligations and Disclosure Requirements) (Third Amendment) Regulations, 2018, please find enclosed herewith the Annual Secretarial Compliance Report duly signed and issued by S. Satheesh Kumar, Practicing Company Secretary, Chennai for the financial year ended on 31st March, 2021. Kindly update the above in your records.

pdf

Oceanaa Biotek Industries Ltd.

14 Jul 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

In reference to the above captioned regulation, we hereby submit the Certificate received from our RTA Bigshare Services Pvt Ltd. Kindly take the same on your records.

pdf

Oceanaa Biotek Industries Ltd.

08 Jul 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Statement Of Investor Complaints For The Quarter Ended June 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 2002 Name of the Signatory :- THOMAS XAVIER JEYARAJDesignation :- Managing Director / Whole Time Director

Oceanaa Biotek Industries Ltd.

30 Jun 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

1. Approved the appointment of Mrs. Anbarasi Thenmozhi Thomas (DIN 09207144) as a Non-Executive Independent Director (Additional Director) on the Board of the Company w.e.f 30th June 2021 based on the recommendation of Nomination and Remuneration Committee to hold office up to the ensuing Annual General Meeting of the company, subject to ratification by the members at the ensuing Annual General Meeting of the company for her appointment as Independent Director. The brief profile of Mrs. Anbarasi Thenmozhi Thomas is enclosed herewith as Annexure - A

pdf

Oceanaa Biotek Industries Ltd.

30 Apr 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In accordance with the provisions of Regulations 10(5) for intention for an inter-se transfer amongst immediate relative under Regulation 10(1)(a)(i) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we have received intimation from the acquirer Mrs. Vimala Joseph for following proposed transfer on 27th April 2021 : Name of the Transferor / Acquirer (Donor) Name of the Transferee / Seller (Donor) No. of Shares proposed to be transferred % of Holding Lithya Joseb Vimala Joseph 32,30,000 23.81% Serrena Joseb Vimala Joseph 20,60,005 15.19% A Joseb Raj Vimala Joseph 7,330 0.054% The acquirer could not complete the acquisition and withdraw the acquisition. In this connection intimation under Regulation 10(5) for the aforementioned withdrawal of acquisition received from the acquirer is enclosed herewith.

pdf

Oceanaa Biotek Industries Ltd.

27 Apr 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Sub: Intimation under Regulation 10(5) for intention for an inter-se transfer amongst immediate relative Regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 In accordance with the provisions of Regulations 10(5) for intention for an inter-se transfer amongst immediate relative under Regulation 10(1)(a)(i) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we have received intimation from the acquirer for following proposed transfer : Name of the Transferor / Acquirer (Donor) Name of the Transferee / Seller (Donor) No. of Shares proposed to be transferred % of Holding Lithya Joseb Vimala Joseph 32,30,000 23.81% Serrena Joseb Vimala Joseph 20,60,005 15.19% A Joseb Raj Vimala Joseph 7,330 0.054% All the shares as aforementioned are inter-se transfer amongst promoter by way of gift and without any consideration.

pdf

Oceanaa Biotek Industries Ltd.

22 Apr 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Format of Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayOceanaa Biotek Industries Ltd 2CINL15549TN2005PLC057919 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: NA Designation: NA EmailId: obil@oceanaabiotek.com Name of the Chief Financial Officer: NA Designation: NA EmailId: obil@oceanaabiotek.com Date: 22/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Oceanaa Biotek Industries Ltd.

21 Apr 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Statement Of Investor Complaints For The Quarter Ended March 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 2002 Name of the Signatory :- XAVIER JEYARAJDesignation :- Managing Director / Whole Time Director

Oceanaa Biotek Industries Ltd.

21 Apr 2021

Company Update

Oceanaa Biotek Industries Ltd - 538019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2021

pdf

Is Oceanaa Biotek Industries Ltd. worth buying?

31 Votes:

Buy 67.74%

Sell 6.45%

Hold 25.81%